Loading...

A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis

OBJECTIVE: We tested whether it is possible to differentiate relapsing-remitting (RR) from secondary progressive (SP) disease stages in patients with multiple sclerosis (MS) using a combination of nuclear magnetic resonance (NMR) metabolomics and partial least squares discriminant analysis (PLS-DA)...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neurology
Main Authors: Dickens, Alex M., Larkin, James R., Griffin, Julian L., Cavey, Ana, Matthews, Lucy, Turner, Martin R., Wilcock, Gordon K., Davis, Benjamin G., Claridge, Timothy D.W., Palace, Jacqueline, Anthony, Daniel C., Sibson, Nicola R.
Format: Artigo
Sprog:Inglês
Udgivet: Lippincott Williams & Wilkins 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4222850/
https://ncbi.nlm.nih.gov/pubmed/25253748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000905
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!